CD4 and COVID-19: Furthermore, based on SARS-COV-2 peptide stimulations, more than approximately 30-fold higher frequencies of AIM+ CD4+ and CD8+ T cells were detected in convalescent patients with COVID-19 compared to unexposed individuals (Supplementary Figure 2B), confirming the accuracy of the detection system and the AIMs.